IMPACT OF PROGRESSION OF DISEASE WITHIN 24 MONTHS (POD24) ON FOLLICULAR LYMPHOMA TREATMENT OUTCOME. A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Alfred Jones, 421712

CD38 EXPRESSION AS AN ADDITIONAL PROGNOSTIC MARKER IN MANTLE CELL LYMPHOMA.

EHA Library, Matteo D'Addona, 421714

RESULTS OF THERAPY FOR BCL2-R+ AND BCL2-R- FOLLICULAR LYMPHOMA

EHA Library, Ekaterina Nesterova, 421716

”REAL-LIFE” DATA OF ZANUBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA - A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Gilad Itchaki, 421717

EXPLORING THE PROGNOSTIC VALUE OF BIOLOGICAL BIOMARKERS NLR AND PLR IN NODAL MANTLE CELL LYMPHOMA

EHA Library, Victor Tomacinschii, 421718

RISK FACTORS AND TREATMENT STRATEGIES OF NON-TRAUMATIC CHYLOTHORAX IN FOLLICULAR LYMPHOMA - A CASE SERIES

EHA Library, Thomas Weber, 421719

BGB-11417-203, AN ONGOING, PHASE 2 STUDY OF SONROTOCLAX (BGB-11417), A NEXT-GENERATION BCL2 INHIBITOR, IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jeffrey Matous, 421720

EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB AND LENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Kim Linton, 421721

CHIDAMIDE IN COMBINATION WITH R-CHOP FOR NEWLY DIAGNOSED B‑CELL NON-HODGKIN LYMPHOMA WITH EPIGENETIC MUTATIONS: PRELIMINARY ANALYSIS FROM THE RESULTS OF A PHASE II STUDY

EHA Library, Hongmei Jing, 421723

QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING OF LONCASTUXIMAB TESIRINE COMBINED WITH MOSUNETUZUMAB AND GLOFITAMAB HELPS GUIDE DOSING FOR PATIENTS WITH DLBCL

EHA Library, Yuezhe Li, 421725

INCIDENCE OF SECOND PRIMARY MALIGNANCIES (SPM) FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR-T)

EHA Library, Charles Pei, 421727

COMPARISON OF DIFFERENT PROGNOSTIC MODELS FOR ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: REAL-WORLD DATA FROM T CELL LYMPHOMA COOPERATION GROUP IN SOUTH CHINA

EHA Library, Qiuyuan Xiang, 421728

PHASE II STUDY OF ORELABRUTINIB, RITUXIMAB AND THIOTEPA (ORT) COMBINED WITH OR WITHOUT HIGH-DOSE MTX THERAPY IN PATIENTS WITH PRIMARY CNS LYMPHOMA

EHA Library, Chunmei Yang, 421730

AI-ASSISTED DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA WITH BONE MARROW INVASION

EHA Library, Xuelian Wu, 421731

A FIRST-IN-HUMAN STUDY OF THE POTENT AND HIGHLY SELECTIVE BTK DEGRADER ABBV-101 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

EHA Library, William Wierda, 421734

CNS PROPHYLAXIS, TREATMENT & OUTCOMES IN HIGH GRADE NON-HODGKIN'S LYMPHOMA: AN EIGHT-YEAR EXPERIENCE

EHA Library, Inova Lee, 421735

PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA WHO ARE POTENTIAL CANDIDATES FOR CAR T-CELL THERAPY

EHA Library, ANNA HIRATSUKA, 421736

OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‑CELL LYMPHOMA (DLBCL) TREATED WITH SYSTEMIC THERAPY FROM REAL‑WORLD EXPERIENCE (ORCHID) STUDY

EHA Library, Catherine Thieblemont, 421737

CLINICAL CHARACTERISTICS AND OUTCOMES OF EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF FEMALE GENITAL TRACK: A RETROSPECTIVE STUDY OF THE HELLENIC COOPERATIVE LYMPHOMA GROUP

EHA Library, Evgenia Verrou, 421739

THE DEFINITION AND USE OF BULK DISEASE IN PHASE 3 LYMPHOMA TRIALS: A COMPREHENSIVE LITERATURE REVIEW

EHA Library, Luke Wang, 421740

INCIDENCE AND SURVIVAL OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS OVER TWO DECADES: A DANISH POPULATION-BASED STUDY

EHA Library, Mads Okkels Birk Lorenzen, 421741

DISTINCT CHARACTERISTICS AND SOCIAL DETERMINANTS IN ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS FROM TORONTO

EHA Library, Tomohiro Aoki, 421742

TREATMENT OUTCOMES OF R-CHOP WITHOUT RADIOTHERAPY FOR UNTREATED LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: SUPPLEMENTARY ANALYSIS OF JCOG0601

EHA Library, Yo Saito, 421748

MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN: SUBGROUP ANALYSES IN PATIENTS (PTS) WITH PRIMARY REFRACTORY OR EARLY RELAPSED LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Manali Kamdar, 421749

A RETROSPECTIVE STUDY ON THE USE OF R-COMP IN TREATMENT OF DLBCL PATIENTS: WHEN A SAMPLE IS NOT BIAS SELECTED

EHA Library, Luigi Rigacci, 421753

TAFASITAMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE US REAL-WORLD SETTING

EHA Library, Kimberly Saverno, 421756

SELINEXOR IN COMBINATION WITH R-EPOCH FOR PATIENTS WITH PREVIOUSLY UNTREATED HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA(DLBCL)

EHA Library, Chaoyu Wang, 421759

EFFICIENCY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH DOUBLE EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Xiaojing Xing, 421766

MITOXANTRONE HYDROCHLORIDE LIPOSOME, GEMCITABINE, VINORELBINE WITH OR WITHOUT RITUXIMAB (GVM±R) IN PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN'S LYMPHOMA

EHA Library, Wei Liu, 421770

REAL-LIFE STUDY OF POLATUZUMAB VEDOTIN, BENDAMUSTINE AND RITUXIMAB FOR STAGE IV HIGH-INTERMEDIATE/HIGH RISK DLBCL OR INDOLENT TRANSFORMED IN RELAPSED/REFRACTORY SITUATION

EHA Library, Andre Pardal, 421772

THE LONG-TERM IMPACT OF RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, REAL WORLD OUTCOMES USING NATIONAL HEALTH INSURANCE DATABASE OF SOUTH KOREA.

EHA Library, Hyun Jung Lee, 421774

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ETOPOSIDE AND PREDNISONE (CMOEP) IN TREATMENT-NAIVE PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A PHASE ONE STUDY

EHA Library, Jingwei Yu, 421775

SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN ELEVEN PATIENTS WITH AIDS-RELATED NON-HODGKIN LYMPHOMA

EHA Library, Jun Liu, 421776

« LONG-TERM RESULTS OF TREATMENT OF PATIENTS WITH THE PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (PCNSL) ACCORDING TO THE “CNS-2015” STUDY»

EHA Library, Daria Koroleva, 421778

ACUTE KIDNEY INJURY WITHIN 30 DAYS FOLLOWING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA

EHA Library, John Sharp, 421779

REAL-WORLD EXPERIENCE OF GLOFITAMAB THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 421782

CLINICAL OUTCOME AND PROGNOSTIC FACTORS OF ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A RETROSPECTIVE SINGLE CENTRE STUDY

EHA Library, Yu Peng, 421783

A RETROSPECTIVE STUDY ON THE EFFICACY AND SAFETY OF CHIDAMIDE AS MAINTENANCE THERAPY OF PERIPHERAL T-CELL LYMPHOMA (PTCL)(NCT05967949)

EHA Library, Haorui Shen, 421786

SEQUENTIAL CD19/22 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY LARGE B-CELL NON-HODGKIN'S LYMPHOMA

EHA Library, Caixia Li, 421787

TWENTY-YEAR SINGLE-CENTER EXPERIENCE TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): ADMINISTER BEST THERAPY FIRST

EHA Library, Sotirios Bristogiannis, 421789

EFFICACY AND SAFETY OF MECAPEGFILGRASTIM IN PREVENTING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ting Niu, 421792

CYCLOPHOSPHAMIDE, MITOXANTRONE HYDROCHLORIDE LIPOSOME, VINCRISTINE, AND PREDNISONE REGIME WITH OR WITHOUT RITUXIMAB (CMOP±R) SHOWS HIGH EFFICACY AS A FIRST-LINE TREATMENT FOR NON-HODGKIN'S LYMPHOMA

EHA Library, Tao You, 421793

XPO-1 INHIBITOR SELINEXOR IN COMBINATION WITH RCHOP IS AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH DOUBLE/TRIPLE-HIT LARGE B-CELL LYMPHOMA.

EHA Library, Haiyan Yang, 421797

DIFFERENT SUBTYPE OF DLBCL PATIENTS TREATED WITH R-CHOP(LIKE) PLUS ORELABRUTINIB REGIMEN: A REAL-WORLD STUDY

EHA Library, Wei Xu, 421800

CHIDAMIDE IN COMBINATION WITH R-CHOP-LIKE CHEMOTHERAPY FOR PREVIOUSLY UNTREATED GERMINAL CENTER B-CELL-LIKE MYC/BCL2 DOUBLE-EXPRESSER DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Wenyu Li, 421803

INCORPORATING RADIATION WITH CAR T-CELL THERAPY  DEMONSTRATED A HIGH RATE OF REMISSION IN PATIENTS WITH B CELL LYMPHOMA INVOLVING THE CNS

EHA Library, Hui Shi, 421805

R-CHOP+X REGIMEN ACHIEVES HIGH RESPONSE RATE AND LONG-TERM SURVIVAL BENEFIT IN THE TREATMENT OF BN2 AND MCD SUBTYPES OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Tingting Chen, 421811

HBV ANTIGEN HBX PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA CHEMORESISTANCE THROUGH THE NF-KB/XIAP PATHWAY

EHA Library, Zhumei Zhan, 421814

EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A REAL-WORLD STUDY IN CHINA

EHA Library, Yuhong Ren, 421815

TOXICITY PROFILE OF THE LMB01 PROTOCOL IN THE TREATMENT OF PATIENTS WITH BURKITT LYMPHOMA

EHA Library, rihab ben sghaier, 421818

EXAMINATION AND TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN ST. PETERSBURG (RUSSIA): DATA FROM REAL-LIFE CLINICAL PRACTICE

EHA Library, Evgenii Kunevich, 421711

CHANGES IN T CELL SUBSETS DURING TREATMENTS ASSOCIATED WITH OUTCOMES IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA

EHA Library, Zhijuan Lin, 421713

OUTCOME OF MANTLE CELL LYMPHOMA WITH UNIFORM PROTOCOL : A NORTH INDIAN TERTIARY CARE CENTER EXPERIENCE

EHA Library, Soumyadeep Datta, 421715

WAVELINE-006: A PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (ZV) ALONE OR IN COMBINATION WITH NEMTABRUTINIB AS SUBSEQUENT-LINE THERAPY IN AGGRESSIVE AND INDOLENT B-CELL MALIGNANCIES

EHA Library, Wojciech Jurczak, 421722

ASSOCIATION OF ATG16L1 RS2241880 AND TP53 RS1042522 WITH CHARACTERISTICS AND COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Andjelina Zivanovic, 421724

PROGNOSTIC ROLE OF NUTRITION-RELATED FACTORS IN PRIMARY GASTROINTESTINAL DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Qiqi Qiao, 421726

QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL PREDICTS COMBINATION ACTIVITY OF CD19-TARGETED LONCASTUXIMAB TESIRINE CO-DOSED WITH A CD20/CD3 T-CELL BISPECIFIC (EPCORITAMAB) IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yuezhe Li, 421732

EVALUATION OF FERTILITY IN WOMEN TREATED WITH THE R-DA-EPOCH REGIMEN FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA (PMBCL)

EHA Library, Angeliki Georgopoulou, 421738

IMPACT OF RESPONSE TO STEROID ADMINISTRATION BEFORE CHEMOIMMUNOTHERAPY ON PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Kikuaki Yoshida, 421743

PRIMARY GASTROINTESTINAL LYMPHOMA – EPIDEMIOLOGY, TREATMENT, AND OUTCOMES IN A 25-YEAR SINGLE CENTER EXPERIENCE

EHA Library, Karla Misura Jakobac, 421744

R2-GDP WITH LENALIDOMIDE MAINTENANCE FOR TRANSPLANT-INELIGIBLE RELAPSE REFRACTORY DLBCL UNDER CLINICAL TRIAL AND REAL-WORLD SETTINGS

EHA Library, Lawrence Ng, 421745

IMPACT OF EXTRAMEDIASTINAL INVOLVEMENT ON SURVIVAL METRICS IN PMBCL PATIENTS: INSIGHTS FROM A UNIFORM R-DA-EPOCH PROTOCOL

EHA Library, Runiza Abdurashidova, 421746

OUTCOMES OF PEDIATRIC AND YOUNG ADULTS’ PATIENTS TREATED FOR LYMPHOBLASTIC LYMPHOMA BY EORTC 58859 PROTOCOL– A SINGLE CENTER EXPERIENCE.

EHA Library, Imen Ben Amor, 421747

INCIDENCE RATES AND TRENDS OF LARGE B-CELL LYMPHOMA IN SPAIN (2002-2016): A POPULATION-BASED STUDY

EHA Library, rafael marcos-gragera, 421751

PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA: OWN EXPERIENCE OF DIAGNOSIS AND EFFECTIVE TREATMENT PROTOCOLS.

EHA Library, Liliya Gorenkova, 421752

REVIEW OF NATIONWIDE INPATIENT REGISTRY TO ANALYZE THE RISK AND OUTCOMES OF TUMOR LYSIS SYNDROME OF PATIENT ADMITTED FOR AGGRESSIVE B CELL LYMPHOMAS.

EHA Library, Muhammad Farooq, 421754

A DIAGNOSTIC PREDICTIVE MODEL FOR DISTINGUISHING INTRAVASCULAR LARGE B-CELL LYMPHOMA IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN

EHA Library, Chao Chen, 421755

EFFICACY AND SAFETY OF POLA-R-CHP THERAPY IN ELDERLY PATIENTS OVER 80 YEARS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD OBSERVATIONAL STUDY

EHA Library, Masaaki Hotta, 421757

COMPARATIVE EFFECTIVENESS OF NHL-BFM-90 AND R-CHOEP CHEMOTHERAPY PROTOCOLS IN HIV-INFECTED PATIENTS WITH BURKITT'S LYMPHOMA

EHA Library, Chingiz Mabudzada, 421758

THE IMPACT OF INTENSIVE CHEMOTHERAPY AND RADIOTHERAPY ON PLASMABLASTIC LYMPHOMA OUTCOMES

EHA Library, Philip Haddad, 421760

ZANBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF OLDER UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARDGE B CELL LYMPHOMA

EHA Library, Hui Liu, 421761

CONSTRUCTION OF A PREDICTIVE MODEL FOR SURVIVAL RISK IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA BASED ON MACHINE LEARNING

EHA Library, Liping Su, 421762

T-CELL/HISTOCYTE B-CELL RICH LYMPHOMA (THRBCL) TREATMENT WITH R-CHOEP PLUS VENETOCLAX (SURVIVAL ADVANTAGE)

EHA Library, Maher Salamoon, 421763

SELINEXOR COMBINED WITH TISLELIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA (R/R ENKTL): RESULTS OF DOSE ESCALATION OF COHORT C FROM PHASE I/II STUDY TOUCH

EHA Library, Rong Tao, 421764

ZANUBRUTINIB IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH POOR PROGNOSTIC GENETIC MUTATIONS: A PROPENSITY SCORE MATCHED ANALYSIS

EHA Library, Wenrong Huang, 421765

THE EFFICACY OF HIGH DOSE METHOTREXATE IN THE PROPHYLAXIS OF CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AT HIGH RISK : A RETROSPECTIVE BICENTRIC STUDY IN REAL LIFE.

EHA Library, CAILLET Adrien, 421767

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: A RETROSPECTIVE STUDY OF A CONSECUTIVE 13-YEAR CASE SERIES

EHA Library, Liang Wang, 421768

REAL WORLD DATA OF ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULT PATIENTS WITH REFRACTORY/RELAPSED HIGH GRADE B CELL LYMPHOMA AND MANTLE CELL LYMPHOMA IN ONE CENTRE IN SOUTHERN GREECE.

EHA Library, Stavros Papadakis, 421769

EXPLORING FRONTIERS: A DECADE OF EARLY PHASE CLINICAL TRIALS AT A LEADING TERTIARY CENTER.

EHA Library, SERGIO RAMOS, 421771

EFFICACY AND SAFETY ANALYSIS OF COMBINATION THERAPY BASED ON MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION IN RELAPSED/REFRACTORY NK/T-CELL LYMPHOMA

EHA Library, Liang Wang, 421777

PHASE 2 SEARCH STUDY：SELINEXOR (ATG-010) MONOTHERAPY IN HEAVILY PRETREATED CHINESE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Song Yuqin, 421780

CONFIRMATION OF THE EXCELLENT OUTCOMES WITH BRENTUXIMAB-NIVOLUMAB FOR RELAPSED REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN THE REAL-WORLD SETTING

EHA Library, Lucy Pickard, 421781

ASSOCIATION OF PAKT1 AND AIF BIOMARKERS WITH THE PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 421784

ACALABRUTINIB IN COMBINATION WITH RITUXIMAB AND REDUCED DOSE CHOP (R-MINICHOP) IN OLDER ADULTS WITH UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA – ARCHED/GLA 2022-1, A GERMAN LYMPHOMA ALLIANCE STUDY

EHA Library, Igor Age Kos, 421785

PROGNOSTIC VALUE OF CACHEXIA INDEX DETERMINED BY BIOELECTRICAL IMPEDANCE ANALYSIS IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS UNDERGOING R-CHOP CHEMOTHERAPY

EHA Library, Young Hoon Park, 421788

PATTERNS OF PRIMARY LARGE B CELL TESTICULAR LYMPHOMA RELAPSES IN THE RITUXIMAB ERA

EHA Library, Suheil Albert Atallah-Yunes, 421790

THE DISPARITY OF CIRCULATING IMMUNE CELL SUBSETS AND INFLAMMATORY STATUS BETWEEN HIV-POSITIVE AND HIV-NEGATIVE PATIENTS WITH LYMPHOMA

EHA Library, Qing Xiao, 421791

ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF UNTREATED NON-GERMINAL CENTER B-CELL SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA WITH MULTIPLE EXTRANODAL INVOLVEMENT.

EHA Library, Caixia Li, 421794

BASELINE MONOCYTE-TO-PLATELETS RATIO (MPR) IS ASSOCIATED WITH INFERIOR PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA: A MULTI-CENTER REAL-LIFE SURVEY

EHA Library, Andrea Duminuco, 421795

PRELIMINARY INVESTIGATION OF THE EFFICACY AND SAFETY OF ZANUBRUTINIB IN COMBINATION WITH R-CHEMO AS FIRST-LINE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

EHA Library, Haiwen Huang, 421796

INCIDENCE, PREVALENCE AND TRENDS OF B CELL LYMPHOMA IN URBAN CHINA: A NATIONWIDE POPULATION-BASED STUDY

EHA Library, Yinchu Cheng, 421799

LINPERLISIB IN COMBINATION WITH CHOP FOR NEWLY-DIAGNOSED PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM THE PHASE 1B/2 LINCH STUDY

EHA Library, Qingqing Cai, 421801

ORELABRUTINIB, RITUXIMAB AND HIGH-DOSE METHOTREXATE (HD-MTX) IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE ANALYSIS ON EFFICACY AND SAFETY

EHA Library, Shujuan Wen, 421802

CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN AGGRESSIVE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM (CNS): RESULTS FROM A RETROSPECTIVE ANALYSIS

EHA Library, Georg-Nikolaus Franke, 421804

NUTRITIONAL STATUS AND INFLUENCING FACTORS ANALYSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES DURING TRANSPLANT COMBINED WITH CAR-T CELL IMMUNOTHERAPY

EHA Library, yabin wang, 421806

A PHASE 1/2 TRIAL INVESTIGATING SAFETY, TOLERABILITY, AND PRELIMINARY ANTITUMOR ACTIVITY OF IPH6501, A FIRST-IN-CLASS NK CELL ENGAGER, IN PATIENTS WITH R/R CD20-EXPRESSING NHL

EHA Library, Lorenzo Falchi, 421807

TRIAL IN PROGRESS: PHASE 1 STUDY OF ARV-393, A PROTAC BCL6 DEGRADER, IN ADVANCED NON-HODGKIN LYMPHOMA

EHA Library, Paolo F Caimi, 421809

REAL-WORLD 7-YEAR SINGLE-CENTER EXPERIENCE IN THE MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Vojin Vukovic, 421813

EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINIB COMBIDED WITH RITUXIMAB AND LENALIDOMIDE FOR REFRACTORY RECURRENT AND NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDELY

EHA Library, Chunxia Zhang, 421816

R-CHOP VERSUS DOSE-ADJUSTED-EPOCH-R AS A FIRST LINE THERAPY IN DOUBLE EXPRESSOR DLBCL A SINGLE CENTER EXPERIENCE

EHA Library, Sofija Pantelic, 421817